← Home

Research use case

Remote monitoring during outpatient cancer treatment

Evidence for electronic symptom monitoring and evidence for passive wearable sensing are related but distinct. They can complement one another; one cannot be used as a substitute for the other.

Audience
For oncology clinics and research centres
Status
Research information, not medical advice
Editorial
NPO NT project team; scientific concept by Dr Artem Poltoratskiy
Review
No independent external medical review of this edition is claimed
Updated
Reviewed 19 August 2026
01

Why ePRO is a separate layer

Pain, nausea, fatigue or breathlessness cannot reliably be inferred from activity or heart rate alone. Patient reports therefore need their own validated questions and response pathway.

02

A minimum safe pathway

  • The patient knows what is monitored and when not to wait for the system.
  • Thresholds, working hours and expected response are documented.
  • Signals go to an accountable team for review, not to the patient as treatment advice.
  • Missing data are never interpreted as stability.
03

What remains to be demonstrated

A device-specific pilot should evaluate data quality, acceptability, false signals, workload and prespecified outcomes in the exact population and treatment pathway.